75 results
Page 2 of 4
SC 14D9
26isgvvbrm ez4lomns1
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
yq67 ideesr
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-99.1
uwe xcn70rm3vc
20 May 22
Regulation FD Disclosure
10:30am
8-K
EX-99.2
rpywl4fpld40csgc
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
zw1lb48 0pql4n4
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
jskk ncfmdxwzp
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
8-K
EX-99.1
aj3l6qhhvrwh
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
kl2d c61nc34
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
b61a0x3sd
7 Mar 22
TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx
7:47am
8-K
clzjos4 izx
3 Jan 22
Other Events
6:03am
8-K
ijinu
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
g7so79 a6ue
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
2m97npt x28vpczz
8 Dec 21
Regulation FD Disclosure
6:55am
8-K
EX-99.2
efejczpgdym1uc kc
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.3
gn2akg3clllzi6urfo
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.1
81ei0fae2s8d9 n22
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am